Active Biotech AB (publ) (FRA:BTPC)
Germany · Delayed Price · Currency is EUR 0.0036
-0.0001 (-2.70%)
At close: Jan 22, 2026
Active Biotech AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
10.41M EUR
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 6.73M | -1.70M | -20.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Turbon AG | 54.96M |
| MedNation AG | 49.96M |
| plenum AG | 29.42M |
| Park & Bellheimer AG | 25.32M |
| Erlebnis Akademie AG | 24.95M |
| Regenbogen AG | 21.90M |
| Beyond Frames Entertainment AB | 15.67M |
| Your Family Entertainment AG | 2.62M |
Active Biotech AB News
- 2 months ago - Active Biotech AB: Active Biotech's patent related to a pharmaceutical formulation of tasquinimod will be granted in the US - Finanz Nachrichten